Search Results - "Perera, Kanjana"

Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update by Hart, Robert G, Catanese, Luciana, Perera, Kanjana S, Ntaios, George, Connolly, Stuart J

“…BACKGROUND AND PURPOSE—Embolic stroke of undetermined source (ESUS) designates patients with nonlacunar cryptogenic ischemic strokes in whom embolism is the…”
Get full text

Intracranial Atherosclerotic Plaque and Embolic Stroke of Undetermined Source: Another Piece of the Puzzle by Hart, Robert G, Perera, Kanjana S

Get full text

Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial by Perera, Kanjana S, Ng, Kelvin K H, Nayar, Sumiti, Catanese, Luciana, Dyal, Leanne, Sharma, Mukul, Connolly, Stuart J, Yusuf, Salim, Bosch, Jackie, Eikelboom, John W, Hart, Robert G

“…The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) randomized clinical trial was stopped early owing to the efficacy of low-dose…”
Get more information

Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry by Meinel, Thomas Raphael, Tsiplova, Kate, Taylor, Amanda, Meseguer, Elena, Haeusler, Karl Georg, Hart, Robert G, Arnold, Marcel, Perera, Kanjana S

“…Background: Chronic ischemic lesions (CILs) are frequent findings in patients with acute ischemic stroke, but their phenotypes and relevance in young adults…”
Get full text

Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials by Hart, Robert G., Katsanos, Aristeidis H., Perera, Kanjana S., Eikelboom, John W.

“…Clinical trials provide conflicting evidence regarding oral factor Xa inhibitors for prevention of ischemic stroke in patients without a history of atrial…”
Get full text

Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]) by Perera, Kanjana S., Pearce, Lesly A., Sharma, Mukul, Benavente, Oscar, Connolly, Stuart J., Hart, Robert G.

“…The mortality rate of most patients with atrial fibrillation (AF) exceeds the stroke rate, but predictors of mortality have not been well defined. The Atrial…”
Get full text

Statin treatment and cerebral microbleeds: A systematic review and meta-analysis by Katsanos, Aristeidis H., Lioutas, Vasileios-Arsenios, Charidimou, Andreas, Catanese, Luciana, Ng, Kelvin Kuan Huei, Perera, Kanjana, de Sa Boasquevisque, Danielle, Falcone, Guido J., Sheth, Kevin N., Romero, Jose Rafael, Tsivgoulis, Georgios, Smith, Eric E., Sharma, Mukul, Selim, Magdy H., Shoamanesh, Ashkan

“…Although statins have been associated with increased risk of spontaneous intracerebral hemorrhage, their relationship with cerebral microbleeds (CMBs)…”
Get full text

Thrombectomy in young adults with embolic stroke of undetermined source: Analysis of the Young ESUS study by Lee, Sarah, Yuan, Fei, Garcia, Madelleine, MacLellan, Adam, Mlynash, Michael, Meseguer, Elena, Arnold, Marcel, Häusler, Karl Georg, Sporns, Peter B., Perera, Kanjana S.

“…Embolic Stroke of Undetermined Source (ESUS) is a distinct stroke entity that disproportionately affects young adults. We sought to describe characteristics,…”
Get full text

Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial by Hart, Robert G., Veltkamp, Roland C., Sheridan, Patrick, Sharma, Mukul, Kasner, Scott E., Bangdiwala, Shrikant I., Ntaios, George, Shoamanesh, Ashkan, Ameriso, Sebastian F., Toni, Danilo, Czlonkowska, Anna, Lindgren, Arne, Hankey, Graeme J., Perera, Kanjana. S., Shuaib, Ashfaq, Coutts, Shelagh B., Gagliardi, Rubens J., Berkowitz, Scott D., Mundl, Hardi, Peters, Gary, Connolly, Stuart J.

“…Background: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic ischemic stroke presumed due to embolism from several…”
Get full text

Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT) by Perera, Kanjana S., Sharma, Mukul, Connolly, Stuart J., Wang, Jia, Gold, Michael R., Hohnloser, Stefan H., Lau, Chu Pak, Van Gelder, Isabelle C., Morillo, Carlos, Capucci, Alessandro, Israel, Carsten W., Botto, Gluca, Healey, Jeffery S.

“…The Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)…”
Get full text

Oral factor Xa inhibitors and risk of subdural hematoma: COMPASS trial results and meta-analysis by Catanese, Luciana, Eikelboom, John W., Bosch, Jackie, Shestakovska, Olga, Ng, Kelvin, Nayar, Sumiti, Perera, Kanjana S., Shoamanesh, Ashkan, Sharma, Mukul, Hart, Robert G.

“…OBJECTIVESubdural hematomas (SDHs) are an uncommon, but important, complication of anticoagulation therapy. We hypothesized that the risks of SDH would be…”
Get full text

Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis by Junek, Mats, Perera, Kanjana S, Kiczek, Matthew, Hajj-Ali, Rula A

“…Abstract Primary CNS vasculitis (CNSV) is a rare, idiopathic autoimmune disease that, if untreated, can cause significant morbidity and mortality. It is a…”
Get full text

Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke: Embolic Stroke of Undetermined Source Global Registry by Perera, Kanjana S, Vanassche, Thomas, Bosch, Jackie, Swaminathan, Balakumar, Mundl, Hardi, Giruparajah, Mohana, Barboza, Miguel A, O’Donnell, Martin J, Gomez-Schneider, Maia, Hankey, Graeme J, Yoon, Byung-Woo, Roxas, Artemio, Lavallee, Philippa, Sargento-Freitas, Joao, Shamalov, Nikolay, Brouns, Raf, Gagliardi, Rubens J, Kasner, Scott E, Pieroni, Alessio, Vermehren, Philipp, Kitagawa, Kazuo, Wang, Yongjun, Muir, Keith, Coutinho, Jonathan M, Connolly, Stuart J, Hart, Robert G

“…BACKGROUND AND PURPOSE—Atrial fibrillation (AF) is increasingly recognized as the single most important cause of disabling ischemic stroke in the elderly. We…”
Get full text

In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 Pandemic by Katsanos, Aristeidis H, de Sa Boasquevisque, Danielle, Al-Qarni, Mustafa Ahmed, Shawawrah, Mays, McNicoll-Whiteman, Rhonda, Gould, Linda, Van Adel, Brian, Sahlas, Demetrios J, Ng, Kelvin Kuan Huei, Perera, Kanjana, Sharma, Mukul, Oczkowski, Wieslaw, Pikula, Aleksandra, Shoamanesh, Ashkan, Catanese, Luciana

“…We investigated the impact of regionally imposed social and healthcare restrictions due to coronavirus disease 2019 (COVID-19) to the time metrics in the…”
Get more information

Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy by Ameriso, Sebastian F., Amarenco, Pierre, Pearce, Lesly A., Perera, Kanjana S., Ntaios, George, Lang, Wilfried, Bereczki, Daniel, Uchiyama, Shinichiro, Kasner, Scott E., Yoon, Byung-Woo, Lavados, Pablo, Firstenfeld, Alfredo, Mikulik, Robert, Povedano, Guillermo Pablo, Ferrari, Jorge, Mundl, Hardi, Berkowitz, Scott D., Connolly, Stuart J., Hart, Robert G.

“…Non-stenotic intracranial and systemic atherosclerosis are associated with ischemic stroke. We report frequency and response to anticoagulant vs. antiplatelet…”
Get full text

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis by Hariharan, Nikhil Nair, Patel, Kashyap, Sikder, Omaike, Perera, Kanjana S, Diener, Hans-Christoph, Hart, Robert G, Eikelboom, John W

“…Purpose We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy and safety of direct oral…”
Get full text

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy by Sharma, Mukul, Smith, Eric E, Pearce, Lesly A, Perera, Kanjana S, Kasner, Scott E, Yoon, Byung-Woo, Ameriso, Sebastian F, Puig, Josep, Damgaard, Dorte, Fiebach, Jochen B, Muir, Keith W, Veltkamp, Roland C, Toni, Danilo S, Shamalov, Nikolay, Gagliardi, Rubens J, Mikulik, Robert, Engelter, Stefan T, Bereczki, Daniel, O’Donnell, Martin J, Saad, Feryal, Shoamanesh, Ashkan, Berkowitz, Scott D, Mundl, Hardi, Hart, Robert G

“…Background Covert brain infarcts are associated with important neurological morbidity. Their incidence in patients with embolic stroke of undetermined source…”
Get full text

Blood Pressure Management Following Endovascular Stroke Treatment: A Feasibility Trial and Meta‐Analysis of Outcomes by Katsanos, Aristeidis H., Catanese, Luciana, Sahlas, Demetrios J., Srivastava, Abhilek, Veroniki, Areti‐Angeliki, Perera, Kanjana, Ng, Kelvin K. H., Joundi, Raed, Van Adel, Brian, Larrazabal, Ramiro, Hawkes, Christine, Deshmukh, Aviraj, Ratnayake, Kanchana, Palaiodimou, Lina, Tsivgoulis, Georgios, Benavente, Oscar, Hart, Robert, Sharma, Mukul, Shoamanesh, Ashkan

“…Background Although postprocedure blood pressure (BP) correlates with outcome in patients undergoing endovascular thrombectomy (EVT), the optimal target is…”
Get full text

Frequency and features of embolic stroke of undetermined source in young adults by Perera, Kanjana S, Swaminathan, Balakumar, Veltkamp, Roland, Arauz, Antonio, Ameriso, Sebastian, Marti-Fabregas, Joan, Arnold, Marcel, Hankey, Graeme J, Lutsep, Helmi, Hart, Robert G

“…Introduction The sources of emboli in those with embolic stroke of undetermined source may differ in old and young. We assessed the frequency, features and…”
Get full text

What's New in Stroke? Phase III Randomized Clinical Trials of 2012–2014 by Hart, Robert G., Ng, Kuan H., Perera, Kanjana S., Shoamanesh, Ashkan

“…Background Randomized clinical trials provide the most reliable evidence to guide the management of stroke and threatened stroke and reflect the interests of…”
Get full text